Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Morgan Stanley
MS
|
+$798M |
| 2 |
AT&T
T
|
+$527M |
| 3 |
Microchip Technology
MCHP
|
+$472M |
| 4 |
Netflix
NFLX
|
+$446M |
| 5 |
PNC Financial Services
PNC
|
+$444M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Goldman Sachs
GS
|
+$694M |
| 2 |
KeyCorp
KEY
|
+$401M |
| 3 |
Deere & Co
DE
|
+$322M |
| 4 |
CSX Corp
CSX
|
+$318M |
| 5 |
NXP Semiconductors
NXPI
|
+$314M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 5.93% |
| 2 | Technology | 4.66% |
| 3 | Healthcare | 4.45% |
| 4 | Industrials | 4.14% |
| 5 | Consumer Discretionary | 3.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MASI
3501
CALL
DELISTED
Masimo
MASI
| $3.14M | ﹤0.01% |
25,200
+14,800
| +142% | +$1.64M |
|
3502
CALL
Molina Healthcare
MOH
$11.1B
| $3.14M | ﹤0.01% |
21,100
+4,300
| +26% | +$549K |
|
3503
AngloGold Ashanti
AU
$48.7B
| $3.14M | ﹤0.01% |
365,538
-84,021
| -19% | -$693K |
|
3504
MillerKnoll
MLKN
$1.62B
| $3.14M | ﹤0.01% |
81,668
+73,701
| +925% | +$2.8M |
|
3505
PUT
Edgewell Personal Care
EPC
$1.31B
| $3.13M | ﹤0.01% |
67,800
+27,600
| +69% | +$1.46M |
|
3506
Genpact
G
$5.69B
| $3.13M | ﹤0.01% |
102,370
-127,529
| -55% | -$3.87M |
|
|
AVX
3507
DELISTED
AVX Corporation
AVX
| $3.13M | ﹤0.01% |
173,591
-94,051
| -35% | -$1.81M |
|
3508
CALL
Cognex
CGNX
$11B
| $3.13M | ﹤0.01% |
56,100
+25,300
| +82% | +$1.3M |
|
3509
Insight Enterprises
NSIT
$4.53B
| $3.13M | ﹤0.01% |
57,898
-41,689
| -42% | -$2.19M |
|
3510
PUT
B&G Foods
BGS
$294M
| $3.13M | ﹤0.01% |
114,000
+65,400
| +135% | +$2.03M |
|
3511
PUT
Kinross Gold
KGC
$32.4B
| $3.13M | ﹤0.01% |
1,158,900
+661,600
| +133% | +$2.14M |
|
|
ARCH
3512
PUT
DELISTED
Arch Resources, Inc.
ARCH
| $3.13M | ﹤0.01% |
35,000
+8,700
| +33% | +$752K |
|
|
BEAT
3513
PUT
DELISTED
BioTelemetry, Inc.
BEAT
| $3.13M | ﹤0.01% |
48,500
+33,200
| +217% | +$1.85M |
|
3514
Ashland
ASH
$3.38B
| $3.12M | ﹤0.01% |
37,240
-167,107
| -82% | -$13.9M |
|
3515
First Trust Financials AlphaDEX Fund
FXO
$1.15B
| $3.12M | ﹤0.01% |
+97,636
| New | +$3.16M |
|
3516
PUT
NCR Voyix
VYX
$1.13B
| $3.12M | ﹤0.01% |
179,137
+70,253
| +65% | +$1.25M |
|
3517
CALL
CenterPoint Energy
CNP
$26.9B
| $3.12M | ﹤0.01% |
112,700
+46,200
| +69% | +$1.29M |
|
|
WIRE
3518
DELISTED
Encore Wire Corp
WIRE
| $3.12M | ﹤0.01% |
62,187
-5,543
| -8% | -$277K |
|
|
SRRA
3519
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
| $3.11M | ﹤0.01% |
45,801
+13,715
| +43% | +$1.24M |
|
3520
iShares Global Healthcare ETF
IXJ
$4.2B
| $3.11M | ﹤0.01% |
49,422
+33,201
| +205% | +$2.01M |
|
3521
Plexus
PLXS
$7.13B
| $3.11M | ﹤0.01% |
53,197
-11,356
| -18% | -$695K |
|
3522
Invesco Variable Rate Preferred ETF
VRP
$3.01B
| $3.11M | ﹤0.01% |
124,963
+76,130
| +156% | +$1.9M |
|
|
AZPN
3523
PUT
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $3.11M | ﹤0.01% |
27,300
+15,400
| +129% | +$1.75M |
|
3524
Cheesecake Factory
CAKE
$5.64B
| $3.11M | ﹤0.01% |
58,044
-1,261,773
| -96% | -$68.2M |
|
3525
Metallus
MTUS
$904M
| $3.11M | ﹤0.01% |
208,955
+56,652
| +37% | +$850K |
|
Similar funds
Ken Griffin's Q3 2018 Portfolio in Review
As of Q3 2018, Ken Griffin held 10,190 positions worth $224B, up 10% from $203B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ken Griffin deployed $7.48B of net new capital in Q3 2018, opening 1,427 new positions and adding to 4,227 existing holdings. Its largest new stake was Alibaba: 1,030,311 shares worth $170M.
By sector, the portfolio is most concentrated in Financials at 5.9% of assets, down from 6.2% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Goldman Sachs, an estimated $694M trimmed.
- Ken Griffin's largest Q3 2018 buy was Alibaba: 1,030,311 shares worth $170M.
- Ken Griffin added most to Morgan Stanley in Q3 2018, an estimated $798M increase.
- Ken Griffin's biggest Q3 2018 reduction was Goldman Sachs, cutting an estimated $694M.
- Ken Griffin fully exited XL Group Ltd. in Q3 2018, selling an estimated $207M.
- Ken Griffin's ten largest holdings make up 25% of its $224B portfolio in Q3 2018.
- Ken Griffin opened 1,427 new positions and closed 1,043 in Q3 2018.
- Ken Griffin's portfolio value rose 10% quarter-over-quarter to $224B.
Based on Citadel Advisors's 13F filing for Q3 2018, filed 13 Nov 2018.